Personalized combination therapies for cancer patients.
Researchers at Stanford took blood samples from patients and sent them to Chicago-based Tempus for genomic sequencing of the person’s cancer. Another sample was sent to Notable, which used its AI-based automated laboratory system to test hundreds of potential drug treatments against the disease and provided treatment recommendations based on that analysis. Stanford clinicians then used this data (alongside the clinical features of the patient) to create a report with individualized recommendations that could inform future treatment.
The partnership between for-profit Notable Labs and nonprofit Cures Within Reach could bring a childhood cancer treatment — a combination discovered by Foster City's Notable Labs of a generic drug and a natural product — to market faster and cheaper.